Advertisement
New Zealand markets open in 6 hours 41 minutes
  • NZX 50

    12,329.44
    +37.41 (+0.30%)
     
  • NZD/USD

    0.6071
    -0.0013 (-0.21%)
     
  • ALL ORDS

    8,272.70
    -30.80 (-0.37%)
     
  • OIL

    82.48
    -0.37 (-0.45%)
     
  • GOLD

    2,471.20
    +11.30 (+0.46%)
     

Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too

Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too

Novavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the coronavirus vaccine race. To make matters worse, earlier this year, Novavax even questioned its ability to continue operations. Jacobs revealed details about his strategy to cut costs, manage cash flow, and match Novavax's size to the demand for its only product: the coronavirus vaccine.